vs

Side-by-side financial comparison of BASSETT FURNITURE INDUSTRIES INC (BSET) and 4D Molecular Therapeutics, Inc. (FDMT). Click either name above to swap in a different company.

4D Molecular Therapeutics, Inc. is the larger business by last-quarter revenue ($85.1M vs $80.1M, roughly 1.1× BASSETT FURNITURE INDUSTRIES INC). 4D Molecular Therapeutics, Inc. runs the higher net margin — 22.8% vs 1.0%, a 21.8% gap on every dollar of revenue. On growth, 4D Molecular Therapeutics, Inc. posted the faster year-over-year revenue change (8508900.0% vs 5.9%). 4D Molecular Therapeutics, Inc. produced more free cash flow last quarter ($28.5M vs $-2.6M). Over the past eight quarters, 4D Molecular Therapeutics, Inc.'s revenue compounded faster (5412.6% CAGR vs -10.7%).

Bassett Furniture Industries, Inc. is a furniture manufacturer and retailer, headquartered in Bassett, Virginia, United States. It was founded in 1902 by John D. Bassett, Charles C. Bassett, Samuel H. Bassett, and Reed L. Stone. Bassett Furniture is one of the oldest furniture manufacturers in Virginia. The company began when the founders, operating a family sawmill in the foothills of the Blue Ridge Mountains, decided to use surplus lumber to produce bedroom furniture. According to oral hist...

4D Molecular Therapeutics is a clinical-stage biotechnology company specializing in the research and development of targeted adeno-associated virus (AAV) gene therapies. Its core product candidates address unmet medical needs in ophthalmology, cardiology, and pulmonary disease segments, serving global patient populations with rare and common hard-to-treat conditions.

BSET vs FDMT — Head-to-Head

Bigger by revenue
FDMT
FDMT
1.1× larger
FDMT
$85.1M
$80.1M
BSET
Growing faster (revenue YoY)
FDMT
FDMT
+8508894.1% gap
FDMT
8508900.0%
5.9%
BSET
Higher net margin
FDMT
FDMT
21.8% more per $
FDMT
22.8%
1.0%
BSET
More free cash flow
FDMT
FDMT
$31.1M more FCF
FDMT
$28.5M
$-2.6M
BSET
Faster 2-yr revenue CAGR
FDMT
FDMT
Annualised
FDMT
5412.6%
-10.7%
BSET

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
BSET
BSET
FDMT
FDMT
Revenue
$80.1M
$85.1M
Net Profit
$801.0K
$19.4M
Gross Margin
56.2%
Operating Margin
0.7%
17.3%
Net Margin
1.0%
22.8%
Revenue YoY
5.9%
8508900.0%
Net Profit YoY
117.8%
139.1%
EPS (diluted)
$0.09
$0.43

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BSET
BSET
FDMT
FDMT
Q4 25
$85.1M
Q3 25
$80.1M
$90.0K
Q2 25
$84.3M
$15.0K
Q1 25
$14.0K
Q4 24
$92.1M
$1.0K
Q3 24
$75.6M
$3.0K
Q2 24
$5.0K
Q1 24
$86.6M
$28.0K
Net Profit
BSET
BSET
FDMT
FDMT
Q4 25
$19.4M
Q3 25
$801.0K
$-56.9M
Q2 25
$1.9M
$-54.7M
Q1 25
$-48.0M
Q4 24
$508.0K
Q3 24
$-4.5M
$-43.8M
Q2 24
$-35.0M
Q1 24
$-1.2M
$-32.4M
Gross Margin
BSET
BSET
FDMT
FDMT
Q4 25
Q3 25
56.2%
Q2 25
55.6%
Q1 25
Q4 24
55.7%
Q3 24
53.0%
Q2 24
Q1 24
55.3%
Operating Margin
BSET
BSET
FDMT
FDMT
Q4 25
17.3%
Q3 25
0.7%
-67983.3%
Q2 25
3.0%
-396373.3%
Q1 25
-383007.1%
Q4 24
-1.3%
Q3 24
-8.4%
-1704400.0%
Q2 24
-849120.0%
Q1 24
-2.7%
-136200.0%
Net Margin
BSET
BSET
FDMT
FDMT
Q4 25
22.8%
Q3 25
1.0%
-63195.6%
Q2 25
2.3%
-364386.7%
Q1 25
-342657.1%
Q4 24
0.6%
Q3 24
-6.0%
-1461433.3%
Q2 24
-699060.0%
Q1 24
-1.4%
-115717.9%
EPS (diluted)
BSET
BSET
FDMT
FDMT
Q4 25
$0.43
Q3 25
$0.09
$-1.01
Q2 25
$0.22
$-0.98
Q1 25
$-0.86
Q4 24
$0.07
Q3 24
$-0.52
$-0.79
Q2 24
$-0.63
Q1 24
$-0.14
$-0.66

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BSET
BSET
FDMT
FDMT
Cash + ST InvestmentsLiquidity on hand
$54.6M
$402.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$165.7M
$505.7M
Total Assets
$324.2M
$566.7M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BSET
BSET
FDMT
FDMT
Q4 25
$402.7M
Q3 25
$54.6M
$305.1M
Q2 25
$59.8M
$293.2M
Q1 25
$321.4M
Q4 24
$59.9M
$424.9M
Q3 24
$56.2M
$501.9M
Q2 24
$541.9M
Q1 24
$58.4M
$525.9M
Stockholders' Equity
BSET
BSET
FDMT
FDMT
Q4 25
$505.7M
Q3 25
$165.7M
$369.0M
Q2 25
$166.8M
$420.9M
Q1 25
$469.7M
Q4 24
$167.3M
$510.6M
Q3 24
$165.0M
$552.9M
Q2 24
$588.3M
Q1 24
$180.6M
$600.6M
Total Assets
BSET
BSET
FDMT
FDMT
Q4 25
$566.7M
Q3 25
$324.2M
$424.0M
Q2 25
$331.3M
$473.6M
Q1 25
$515.7M
Q4 24
$341.2M
$560.4M
Q3 24
$335.9M
$604.0M
Q2 24
$620.1M
Q1 24
$361.4M
$629.9M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BSET
BSET
FDMT
FDMT
Operating Cash FlowLast quarter
$-1.2M
$28.6M
Free Cash FlowOCF − Capex
$-2.6M
$28.5M
FCF MarginFCF / Revenue
-3.3%
33.5%
Capex IntensityCapex / Revenue
1.8%
0.1%
Cash ConversionOCF / Net Profit
-1.47×
1.47×
TTM Free Cash FlowTrailing 4 quarters
$-109.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BSET
BSET
FDMT
FDMT
Q4 25
$28.6M
Q3 25
$-1.2M
$-46.5M
Q2 25
$-43.4M
Q1 25
$-47.8M
Q4 24
$-134.6M
Q3 24
$5.4M
$-29.4M
Q2 24
$-30.2M
Q1 24
$-7.7M
$-29.1M
Free Cash Flow
BSET
BSET
FDMT
FDMT
Q4 25
$28.5M
Q3 25
$-2.6M
$-46.6M
Q2 25
$-43.4M
Q1 25
$-48.4M
Q4 24
$-138.4M
Q3 24
$2.8M
$-31.2M
Q2 24
$-30.6M
Q1 24
$-9.8M
$-29.8M
FCF Margin
BSET
BSET
FDMT
FDMT
Q4 25
33.5%
Q3 25
-3.3%
-51765.6%
Q2 25
-289620.0%
Q1 25
-345635.7%
Q4 24
-13837100.0%
Q3 24
3.7%
-1038966.7%
Q2 24
-611840.0%
Q1 24
-11.3%
-106421.4%
Capex Intensity
BSET
BSET
FDMT
FDMT
Q4 25
0.1%
Q3 25
1.8%
101.1%
Q2 25
440.0%
Q1 25
4507.1%
Q4 24
378600.0%
Q3 24
3.5%
59266.7%
Q2 24
6980.0%
Q1 24
2.4%
2535.7%
Cash Conversion
BSET
BSET
FDMT
FDMT
Q4 25
1.47×
Q3 25
-1.47×
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BSET
BSET

Retail Segment$51.9M65%
Bassett Custom Upholstery$18.7M23%
Accessories Mattresses And Other$6.9M9%
Bassett Custom Wood$2.7M3%

FDMT
FDMT

Segment breakdown not available.

Related Comparisons